#endhiv

Inspired by Sia's "Free Me" and Matisse's "Dance".  100% Proceeds of online sale of this print will be donate to #endHIV  ENDHIV.COM

http://joeyart.bigcartel.com/product/free-me

you can see her video

Sia - Free Me (starring Zoe Saldana & narrated by Julianne Moore) The song will be available digitally everywhere on Friday. All proceeds from this song will be donated to #endHIV. Join Sia, Zoe Saldana, and Julianne Moore to help break HIV and end AIDS.  Visit http://endhiv.com to learn more about a promising vaccine and donate to the trials. ❤️

🌍 World AIDS Day – 1 December 2025 Unite to End HIV

❤️Genemedi supplies the exact antigens used in millions of HIV tests:

🔴 Gen-3 HIV Antigen → Recombinant gp120 + gp41 + gp36 Detects total antibodies (IgG + IgM + IgA) to HIV-1 & HIV-2

🟢 Gen-4 HIV Antigen & Antibody → Recombinant gp120 + gp41 + gp36 + p24 antigen + anti-p24 monoclonal Detects p24 antigen + total antibodies (IgG + IgM + IgA)

Ready to use • Top quality • Fast delivery • Best price Every early test saves a life. We are proud to help make it happen.

Imagine a world where HIV is no longer a death sentence—where everyone, everywhere, can get vaccinated safely, effectively, and affordably. With the new long-acting HIV shots, this is within reach. We have been waiting all of our lives for this chance to be vaccinated against this deadly disease and the economics are so good. But the Trump Administration has suspended all outlets for this amazing miracle to reach humanity. This has to be remedied and the Crowns are the ones that must do it. This is their holy duty to ensure their capabilities to help mankind to prosper reach every end of this planet.

Current Cutting-Edge Shots

AAV-based HIV vaccine candidates – in phase 3 trials, showing 70–90% protection in high-risk populations.

Cabotegravir long-acting injection (brand: Cabenuva) – already FDA-approved for HIV prevention, given every 2 months.

VRC07-523LS – monoclonal antibody injection providing 6-month protection.

Combination HIV/PrEP long-acting shots – under development, potentially once or twice per year.

How Many Shots Would the World Need?

Target: All adults aged 15+ (~4 billion people)

Frequency: 1–2 doses/year depending on the shot type

Doses/year: 4B (once) → 8B (twice)

Cost to Protect the World

Vaccine cost per dose: $100 (global-scale manufacturing)

Distribution & administration: $20 per dose (cold chain, clinics, healthcare workers)

Total per dose: $120

Global Program Cost

Once per year: 4B × $120 = $480B

Twice per year: 8B × $120 = $960B

Extra for outreach, rural coverage, and monitoring: ~$25–30B

How Central Banking Can Fund It

Central bank sovereign credit issues non-debt, interest-free funds for vaccine production and delivery

Rapid, tax-free deployment worldwide

Fully auditable through WHO, UNICEF, and national health authorities

Insulates the program from market volatility, global crises, and geopolitical pressures

Cost Savings & Economic Impact

Prevented new HIV cases: ~1.35 million per year (if vaccine is 90% effective)

Direct treatment cost savings: ~$6.75B/year

Indirect benefits: healthier workforce, higher productivity, reduced hospitalization, reduced social welfare costs

Multiplier effect: GDP growth, increased household income, higher tax revenue

Legislation Needed

Global HIV Prevention Act (GHIVPA)

Authorizes central banks to fund universal HIV vaccination via sovereign credit.

Covers vaccine procurement, distribution, administration, and monitoring.

Ensures ethical, equitable distribution without discrimination.

Requires annual independent audit and quarterly reporting to global health authorities.

Establishes immediate rollout within 12 months of enactment.

Why This Will Save Lives AND Money

One-time investment in prevention prevents lifelong treatment costs.

Centralized funding eliminates reliance on donor fatigue or taxes.

Protects populations in low-income countries, rural areas, and conflict zones.

Strengthens global health security and workforce productivity.

Call to Action

Support legislation like GHIVPA

Fund global vaccine access using innovative central bank methods

📢 What is Viral Load? 🦠

Viral load refers to the amount of HIV in the bloodstream, measured in copies per milliliter of blood. A higher viral load means more active virus replication, while a lower viral load indicates better control of the infection—especially with HIV treatment. Keeping viral load low is crucial for managing HIV and reducing transmission risk.

✅ Know your numbers. Stay informed. Protect your health.

🦠 The Progression of HIV: What You Need to Know 🦠

HIV doesn’t show symptoms right away, but it progresses over time:

⚡ Window Period – Newly infected, but tests may not detect it yet.

🛡️ Asymptomatic Stage – No symptoms for years, but the virus is active.

🚨 Symptomatic Stage – The immune system weakens, leading to infections.

Early detection & treatment with ART can help manage HIV and prevent progression. Stay informed, get tested, and protect your health! ❤️